Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT00435812
Eligibility Criteria:
Inclusion Criteria:
* Willing and able to give written informed consent
* Is serum negative for HBV antibodies
Exclusion Criteria:
* Women who are pregnant or breastfeeding
* Any previous HBV infection
* Previous vaccination with any HBV vaccine (1 or more doses)
* Any autoimmune disease
* Received any blood products or antibodies within 3 months prior to study entry
* Ever received an injection with DNA plasmids or oligonucleotides
* Received any vaccines within 4 weeks prior to study entry
* Received any other investigational medicinal agent within 4 weeks prior to study entry
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
11 Years
Maximum Age:
55 Years
Study:
NCT00435812
Study Brief:
Protocol Section:
NCT00435812